Amy Kim, MD
MOHS-Micrographic Surgery · Atlanta, GANPI 1457312019
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 30.1% of the total. Reporting peaked in 2024 at $188 and has fallen 65.4% since, to $65 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in GA, where the typical reported total is $3,443.
Across 16 payments — averaging $26.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$130
- Kerecis Limited$48
- Sanofi$47
- Regeneron Healthcare Solutions, Inc.$38
- LEO Pharma Inc.$32
- Verrica Pharmaceuticals Inc.$30
- plus $107 from 5 others
What the payments were for
- Food & beverage$430100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 4 | $130 |
| Kerecis Limited | 1 | $48 |
| Sanofi | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| LEO Pharma Inc. | 2 | $32 |
| Verrica Pharmaceuticals Inc. | 1 | $30 |
| Merz North America, Inc. | 1 | $25 |
| Boehringer Ingelheim | 1 | $24 |
| Pfizer | 1 | $22 |
| BD | 1 | $20 |
| Genentech USA, Inc. | 1 | $16 |
How this compares
$430 in reported general payments places this provider in the 10th percentile of 40 mohs-micrographic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 563 | $3,557 |
| Fluorouracil | 36 | $3,035 |
| Clobetasol Propionate | 19 | $917 |
| Metronidazole | 11 | $676 |
| Doxycycline Hyclate | 46 | $625 |
| Ketoconazole | 24 | $308 |
| Montelukast Sodium | 21 | $277 |
| Triamcinolone Acetonide | 21 | $224 |
| Hydroxyzine Hcl | 14 | $93 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $68 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Atlanta
- David OlanskyAtlanta$13K
- Diamondis PapadopoulosAtlanta$9K
- Melissa BabcockAtlanta$3K
- Humza IlyasAtlanta$3K
- Julia NeckmanAtlanta$3K
- Valerie TruongAtlanta$2K
- Mary Alice MinaAtlanta$533
- Mark BaucomAtlanta$146
- Wallace NozileStockbridge$213K
- Brandon BurrowayDuluth$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.